1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Holly LaFon
Holly LaFon
Articles (7526) 

Invesco European Growth Fund Comments on MorphoSys

November 11, 2013 | About:

MorphoSys (XTER:MOR) is a German biotechnology company with a proprietary technology to develop human antibodies for specific diseases. The company signed two licensing deals (with GlaxoSmithKline PLC and Celgene Corp.) for its proprietary compounds, providing outside validation for its technology as well as upfront cash and future royalty payments.

From Invesco European Growth Fund’s third quarter 2013 commentary.


Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


GuruFocus has detected 6 Warning Signs with MorphoSys AG $XTER:MOR.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.

Performances of the stocks mentioned by Holly LaFon


User Generated Screeners


Matt SaddingtonVeriluma
andrewbulgarelliF-Score with P/B
pbarker46Banks
pbarker46Begin here 1
KetsinyongBank ROA<1%
zmodpEVDE Micro indu
zmodpEVDE Micro
samahajoeIndustry best
pbarker46Price to Tangible Book
samahajoePB-ROE-2
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK